[Monoclonal antibodies in diagnosis and therapy]

H Huland; P Hammerer

[Monoclonal antibodies in diagnosis and therapy]

Immun Infekt. 1989 Feb;17(1):28.

[Article in German]

Authors

H Huland¹, P Hammerer

Affiliation

¹ Urologische Klinik, FU Berlin, Klinikum Steglitz.

PMID: 2647624

Abstract

The value of monoclonal antibodies (mAb) produced against renal, bladder and prostate cancer antigens is demonstrated. These mAb allow a molecular classification of urological cancers as well as therapeutic approaches in cancer treatment. Anti-T-cell mAb can also be used in cellular rejection of kidney transplants.

Publication types

English Abstract
Review

MeSH terms

Antibodies, Monoclonal* / therapeutic use
Antigens, Differentiation, T-Lymphocyte / immunology
Antigens, Neoplasm / immunology*
Humans
Kidney Neoplasms / diagnosis*
Kidney Neoplasms / therapy
Kidney Transplantation
Male
Prostatic Neoplasms / diagnosis*
Prostatic Neoplasms / therapy
Urinary Bladder Neoplasms / diagnosis*
Urinary Bladder Neoplasms / therapy

Substances

Antibodies, Monoclonal
Antigens, Differentiation, T-Lymphocyte
Antigens, Neoplasm